Infectious disease
Infections clinical trials
Bacterial, viral, and other infections — from common illnesses to emerging threats. We’re tracking 4,178 recruiting studies in this area right now.
By phase
- Not applicable2,713
- Phase 2361
- Phase 4321
- Phase 1290
- Phase 3288
- Phase 1/Phase 2141
- Phase 2/Phase 364
Top conditions
Leading sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)89
- Assistance Publique - Hôpitaux de Paris80
- University of California, San Francisco44
- Johns Hopkins University31
- Hospices Civils de Lyon30
- National Cancer Institute (NCI)28
- University of Washington27
- University Hospital, Strasbourg, France26
- Columbia University23
- University of Alabama at Birmingham23
Where studies are running
- California235
- Maryland146
- Alabama89
- New York76
- Florida74
- Texas61
- Massachusetts56
- Arizona47
- Pennsylvania45
- Illinois42
Recruiting studies4,178 total
- NCT07095192Recruiting
Hepatitis C testing and treatment study in Canada
This study looks at how to make hepatitis C testing and treatment easier to access in Canada. It involves different people, like those at risk, healthcare workers, and policy makers, to find better ways to offer care.
Montreal, QuebecAges 18 years+ - NCT07095361RecruitingPhase 4
Daily enzyme therapy for infected pleural fluid
This trial tests a once-daily enzyme treatment given through a chest tube to clear infected fluid from around the lungs. It may help people with complicated pneumonia or empyema who still have fluid buildup after initial drainage.
New Haven, ConnecticutAges 18 years+ - NCT07096284Recruiting
Study of a blood oxygen ratio in septic shock
This trial tests a new way to measure oxygen levels in the blood of patients with septic shock. It may help doctors better understand how well the body is using oxygen.
Marrakesh, MarrakeshAges 18 years+ - NCT07097012RecruitingPhase 4
Whooping cough and RSV vaccines: together or separate in pregnancy
This study tests whether giving two vaccines—one for whooping cough (Tdap) and one for RSV—at the same time is safe and effective compared to giving them separately during pregnancy. It may help protect your baby from both diseases early in life.
Vancouver, British ColumbiaAges 18–49 - NCT07097363RecruitingPhase 2
Epcoritamab plus chemo for aggressive B-cell lymphoma
This trial tests a new drug, epcoritamab, added to a standard chemotherapy regimen (DA-EPOCH-R) for people with aggressive B-cell non-Hodgkin lymphoma that hasn't been treated before or has had only one round of chemo. It aims to see if this combination works better against certain high-risk types of lymphoma.
Seattle, WashingtonAges 18 years+ - NCT07097480Recruiting
Study on virus spread from monkey bites to people
This study looks at whether viruses can be transmitted to people who have been bitten by a non-human primate (like a monkey). It aims to understand the risk and gather information that could help prevent infection.
ParisAges 18 years+ - NCT07099157RecruitingPhase 4
Brivudine for Shingles: Safety and Effectiveness Study
This trial tests whether the antiviral drug brivudine is safe and effective for treating shingles (herpes zoster). It compares brivudine to other antiviral treatments like famciclovir, and may be an option if you are looking for a shorter treatment course.
BeijingAges 18 years+ - NCT07099976Recruiting
Better pneumonia treatment for kids in the ER
This trial tests a treatment plan for children with pneumonia who can be treated at home. It aims to find the best way to help kids get better faster and avoid complications.
Calgary, AlbertaAges 6 months–18 years - NCT07100574Recruiting
Bacteria in dental plaque and artery plaque study
This study looks at bacteria found in dental plaque and in the fatty buildup inside your arteries. It might help researchers understand links between mouth health and blood vessel health after your endarterectomy surgery.
IstanbulAges 18–85 - NCT07103148RecruitingPhase 3
Study of a Yellow Fever Vaccine in Young Children
This trial tests a new yellow fever vaccine in young children. It will see if the vaccine is safe and produces a good immune response, including when given with the MMR vaccine.
San Pedro SulaAges 9 months–5 years - NCT07103356Recruiting
Water pitcher filter to reduce arsenic in well water
This study gives eligible New Hampshire residents a special water pitcher filter that helps remove arsenic from well water. The study team will check if the filter works well over time and if people can use it easily at home.
Lebanon, New HampshireAges 18 years+ - NCT07103707Recruiting
Open vs. laparoscopic gallbladder surgery infection risk
This trial looks at whether healing after gallbladder removal is better when the surgery is done with a few small cuts (laparoscopy) versus one larger cut (open surgery). It may help you avoid wound infections.
Peshawar, Khyber PakhtunkhwaAges 18–65 - NCT07104019Recruiting
Biofiller for Thinning Gums: A Gum-Thickening Study
This study tests a biofiller to make thin gums thicker in the lower front teeth area. It may help people with thin gums who want to improve their gum health and appearance.
MalatyaAges 18–65 - NCT07104162RecruitingPhase 1
Testing an IV antibiotic in people with kidney problems
This study tests an IV antibiotic (cefiderocol/xeruborbactam) in people with different levels of kidney function, including those on dialysis. It aims to see how the drug is processed by the body and whether it is safe.
Miami, FloridaAges 18–80 - NCT07105969Recruiting
Studying coated mini-screws for tooth movement
This trial tests whether special coated mini-screws placed in the jaw can help move teeth and resist infection. It's for teens and young adults getting premolars removed as part of braces treatment.
Al Mansurah, Dakahlia GovernorateAges 16–20 - NCT07106580RecruitingPhase 1/Phase 2
Fecal transplant capsules for clearing drug-resistant bacteria from the gut
This trial tests whether taking capsules containing processed healthy donor stool (fecal microbiota transplant) can safely remove certain drug-resistant bacteria (like CRE, ESBL-E, and VRE) from your intestines. It may be an option for people who have these bacteria in their stool but are not currently being treated with antibiotics.
RijekaAges 18 years+ - NCT07106749RecruitingPhase 1
CD180 car T cells for blood cancers that came back
This trial tests a new CAR T cell therapy that targets a protein called CD180 on cancer cells. It is for people with certain types of relapsed or refractory leukemia or lymphoma that has not responded to standard treatments.
Tianjin, Tianjin MunicipalityAges 18–70 - NCT07107685Recruiting
Joint replacement infections in critical care patients
This trial looks at infections in hip, knee, or shoulder replacements in people who needed critical care and later passed away. It aims to learn from their medical information to better prevent and treat similar infections.
Paris, FranceAges 18 years+ - NCT07107932Recruiting
Registry for Tetanus Prevention After Injury
This registry collects information on people who receive the study drug Siltartoxatug to prevent tetanus after an injury. It helps researchers learn more about how the drug works in real-world use.
Shantou, GuangdongAges Any age - NCT07108036RecruitingPhase 2
Testing Anktiva for Long COVID Symptoms
This trial tests a medicine called Anktiva to see if it can help people with Long COVID. It's for adults who had a confirmed COVID-19 infection and now have lasting symptoms like fatigue, brain fog, or trouble breathing.
San Francisco, CaliforniaAges 18–70 - NCT07108660Recruiting
Predicting and reducing bloodstream infections from central lines
This trial uses machine learning to predict infections that can happen with central lines (special IVs placed in large veins) and aims to reduce how often they occur. It focuses on hospitals with the highest infection rates, so you might be eligible if you receive care at one of these hospitals.
Anchorage, AlaskaAges 18 years+ - NCT07109219RecruitingPhase 1/Phase 2
Study of AZD4512 for adults and teens with relapsed B-ALL
This trial tests a new drug called AZD4512, alone or with other cancer drugs, for people whose B-ALL has come back or did not respond to treatment. It may be an option if you have tried at least 2 prior therapies or have no standard options left.
Duarte, CaliforniaAges 12 years+ - NCT07109765Recruiting
Secukinumab for moderate to severe hidradenitis suppurativa
This study tests a drug called secukinumab (a type of biologic that targets inflammation) for people with moderate to severe hidradenitis suppurativa (HS). It may be an option if you have tried other treatments and they didn't work well.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07109856Recruiting
A new tool to predict infection in newborns
This study tests a simple non-invasive score that uses blood flow in muscles to predict if a newborn has or will develop high inflammation levels (C-reactive protein). It may help doctors start treatment earlier in babies with breathing problems.
Graz, StyriaAges birth–6 hours
Common questions
- How many infections clinical trials are recruiting?
- Clin2 is tracking 4,178 recruiting infectious disease studies from the U.S. registry right now, out of 7,113 we cover in this area in total.
- What does “Infections” cover here?
- Bacterial, viral, and other infections — from common illnesses to emerging threats. We group each study into infections based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a infections trial near me?
- Use the search to filter infections studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.